HUP0301082A2 - Új polimorf olanzapine hidroklorid sók, eljárás ezek előállítására, az ezeket tartalmazó gyógyászati készítmények és felhasználásuk - Google Patents

Új polimorf olanzapine hidroklorid sók, eljárás ezek előállítására, az ezeket tartalmazó gyógyászati készítmények és felhasználásuk

Info

Publication number
HUP0301082A2
HUP0301082A2 HU0301082A HUP0301082A HUP0301082A2 HU P0301082 A2 HUP0301082 A2 HU P0301082A2 HU 0301082 A HU0301082 A HU 0301082A HU P0301082 A HUP0301082 A HU P0301082A HU P0301082 A2 HUP0301082 A2 HU P0301082A2
Authority
HU
Hungary
Prior art keywords
producing
pharmaceutical compositions
compositions containing
polymorphous forms
hydrochloride
Prior art date
Application number
HU0301082A
Other languages
English (en)
Inventor
János Pethő
József Barkóczy
Nagy Péter Kótay
Gyula Simig
Zsuzsanna Szent-Királlyi
Original Assignee
EGIS Gyógyszergyár Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EGIS Gyógyszergyár Rt. filed Critical EGIS Gyógyszergyár Rt.
Priority to HU0301082A priority Critical patent/HU226410B1/hu
Publication of HU0301082D0 publication Critical patent/HU0301082D0/hu
Priority to CZ20050684A priority patent/CZ2005684A3/cs
Priority to PT04728854T priority patent/PT1620439E/pt
Priority to SK5094-2005A priority patent/SK50942005A3/sk
Priority to JP2006506249A priority patent/JP4763594B2/ja
Priority to CN2008101254419A priority patent/CN101468999B/zh
Priority to DK04728854T priority patent/DK1620439T3/da
Priority to PL378061A priority patent/PL378061A1/pl
Priority to PCT/HU2004/000042 priority patent/WO2004094433A1/en
Priority to EA200501633A priority patent/EA008376B1/ru
Priority to ES04728854T priority patent/ES2310728T3/es
Priority to UAA200510999A priority patent/UA80881C2/xx
Priority to CNB2004800106655A priority patent/CN100471859C/zh
Priority to ZA200508936A priority patent/ZA200508936B/en
Priority to AT04728854T priority patent/ATE401332T1/de
Priority to KR1020057020041A priority patent/KR20060004954A/ko
Priority to PL04728854T priority patent/PL1620439T3/pl
Priority to CA2522734A priority patent/CA2522734C/en
Priority to US10/553,908 priority patent/US7951798B2/en
Priority to AU2004232544A priority patent/AU2004232544B2/en
Priority to SI200430885T priority patent/SI1620439T1/sl
Priority to EP04728854A priority patent/EP1620439B1/en
Priority to DE602004015096T priority patent/DE602004015096D1/de
Publication of HUP0301082A2 publication Critical patent/HUP0301082A2/hu
Priority to IL171522A priority patent/IL171522A/en
Priority to BG109361A priority patent/BG109361A/bg
Priority to HR20080479T priority patent/HRP20080479T3/xx
Publication of HU226410B1 publication Critical patent/HU226410B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány 2-metil-4-(4-metil-piperazin-l-il)-l0H-tieno[2,3-b][1,5]benzodiazepin-hidroklorid három (I, II és III) új polimorfjára,ezek előállítására és gyógyászati hatóanyagként történőfelhasználására, valamint az új polimorfokat tartalmazó gyógyászatikészítményekre vonatkozik. A találmány szerinti új polimorfokantipszichotikus gyógyászati hatóanyagként alkalmazhatók. Ó
HU0301082A 2003-04-22 2003-04-22 Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them HU226410B1 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
HU0301082A HU226410B1 (en) 2003-04-22 2003-04-22 Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
DE602004015096T DE602004015096D1 (de) 2003-04-22 2004-04-22 Neue polymorphe von olanzapin-hydrochlorid
CNB2004800106655A CN100471859C (zh) 2003-04-22 2004-04-22 奥氮平盐酸盐新的多晶型
AT04728854T ATE401332T1 (de) 2003-04-22 2004-04-22 Neue polymorphe von olanzapin-hydrochlorid
SK5094-2005A SK50942005A3 (sk) 2003-04-22 2004-04-22 Polymorfy hydrochloridu olanzapínu
JP2006506249A JP4763594B2 (ja) 2003-04-22 2004-04-22 オランザピン・塩酸塩の新規な多形体
CN2008101254419A CN101468999B (zh) 2003-04-22 2004-04-22 奥氮平盐酸盐新的多晶型
DK04728854T DK1620439T3 (da) 2003-04-22 2004-04-22 Hidtil ukendte polymorfer af olanzapinhydrochlorid
PL378061A PL378061A1 (pl) 2003-04-22 2004-04-22 Nowe formy polimorficzne chlorowodorku olanzapiny
PCT/HU2004/000042 WO2004094433A1 (en) 2003-04-22 2004-04-22 New polymorphs of olanzapine hydrochloride
EA200501633A EA008376B1 (ru) 2003-04-22 2004-04-22 Новые полиморфные формы оланзапина гидрохлорида
ES04728854T ES2310728T3 (es) 2003-04-22 2004-04-22 Nuevos polimorfos de hidrocloruro de olanzapina.
UAA200510999A UA80881C2 (en) 2003-04-22 2004-04-22 New polymorphs of olanzapine hydrochloride
CZ20050684A CZ2005684A3 (cs) 2003-04-22 2004-04-22 Polymorfy hydrochloridu olanzapinu
ZA200508936A ZA200508936B (en) 2003-04-22 2004-04-22 New polymorphs of olanzapine hydrochloride
PT04728854T PT1620439E (pt) 2003-04-22 2004-04-22 Novos polimorfos de cloridrato de olanzapina
KR1020057020041A KR20060004954A (ko) 2003-04-22 2004-04-22 올란자핀 히드로클로라이드의 다형체
PL04728854T PL1620439T3 (pl) 2003-04-22 2004-04-22 Nowe formy polimorficzne chlorowodorku olanzapiny
CA2522734A CA2522734C (en) 2003-04-22 2004-04-22 New polymorphs of olanzapine hydrochloride
US10/553,908 US7951798B2 (en) 2003-04-22 2004-04-22 Polymorphs of olanzapine hydrochloride
AU2004232544A AU2004232544B2 (en) 2003-04-22 2004-04-22 New polymorphs of olanzapine hydrochloride
SI200430885T SI1620439T1 (sl) 2003-04-22 2004-04-22 Novi polimorfi olanzapin hidroklorida
EP04728854A EP1620439B1 (en) 2003-04-22 2004-04-22 New polymorphs of olanzapine hydrochloride
IL171522A IL171522A (en) 2003-04-22 2005-10-20 Polymorphs of olanzapine hydrochloride
BG109361A BG109361A (bg) 2003-04-22 2005-11-22 Нови полиморфни форми на оланзапин хидрохлорид
HR20080479T HRP20080479T3 (en) 2003-04-22 2008-09-26 New polymorphs of olanzapine hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0301082A HU226410B1 (en) 2003-04-22 2003-04-22 Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
HU0301082D0 HU0301082D0 (en) 2003-06-28
HUP0301082A2 true HUP0301082A2 (hu) 2004-12-28
HU226410B1 HU226410B1 (en) 2008-11-28

Family

ID=89981318

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301082A HU226410B1 (en) 2003-04-22 2003-04-22 Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them

Country Status (24)

Country Link
US (1) US7951798B2 (hu)
EP (1) EP1620439B1 (hu)
JP (1) JP4763594B2 (hu)
KR (1) KR20060004954A (hu)
CN (2) CN101468999B (hu)
AT (1) ATE401332T1 (hu)
AU (1) AU2004232544B2 (hu)
BG (1) BG109361A (hu)
CA (1) CA2522734C (hu)
CZ (1) CZ2005684A3 (hu)
DE (1) DE602004015096D1 (hu)
DK (1) DK1620439T3 (hu)
EA (1) EA008376B1 (hu)
ES (1) ES2310728T3 (hu)
HR (1) HRP20080479T3 (hu)
HU (1) HU226410B1 (hu)
IL (1) IL171522A (hu)
PL (2) PL378061A1 (hu)
PT (1) PT1620439E (hu)
SI (1) SI1620439T1 (hu)
SK (1) SK50942005A3 (hu)
UA (1) UA80881C2 (hu)
WO (1) WO2004094433A1 (hu)
ZA (1) ZA200508936B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300324A1 (en) * 2002-12-24 2004-07-22 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
SI21850A (sl) * 2004-07-28 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Soli olanzapina in njihova pretvorba v prosto bazo olanzapina
EP2623095A1 (en) * 2004-11-16 2013-08-07 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
HUP0501046A2 (en) 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
KR20090045233A (ko) * 2006-07-10 2009-05-07 파이온 유케이 리미티드 속효형 벤조디아제핀 염 및 이의 중합체 형태
WO2008151430A1 (en) * 2007-06-14 2008-12-18 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
US20090286294A1 (en) * 2008-04-04 2009-11-19 University Of Massachusetts Methods and Compositions for Improving the Production of Fuels in Microorganisms
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
DK2729474T3 (en) * 2011-07-08 2018-05-22 Lilly Co Eli (THIENO [2,3-b] [1,5] BENZOXAZEPIN-4-YL) PIPERAZIN-1-YL COMPOUNDS AS H1-INVERSE AGONISTS / 5-HT2A DOUBLE EFFECTS
RS56538B1 (sr) * 2013-01-14 2018-02-28 Lilly Co Eli (tieno[2,3-b][1,5]benzoksazepin-4-il)piperazin-1-il jedinjenja kao dvostruko delujućih h1 inverzni agonisti/5-ht2a antagonisti
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
KR101489062B1 (ko) * 2013-03-28 2015-02-02 동아에스티 주식회사 고순도의 올란자핀 및 이의 결정형 ii의 제조방법
JP6940866B2 (ja) * 2017-06-21 2021-09-29 国立研究開発法人情報通信研究機構 半導体光デバイス、半導体光源、光集積回路、及び半導体光デバイスの製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
JP4503826B2 (ja) * 1997-09-30 2010-07-14 イーライ リリー アンド カンパニー ２−メチル−チエノ−ベンゾジアゼピン製剤
BR9914156A (pt) 1998-09-30 2001-06-26 Lilly Co Eli Formulação de 2-metil-tieno-benzodiazepina
UA80095C2 (en) * 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
WO2005070938A1 (en) * 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine

Also Published As

Publication number Publication date
KR20060004954A (ko) 2006-01-16
CN101468999B (zh) 2012-05-09
WO2004094433A1 (en) 2004-11-04
DE602004015096D1 (de) 2008-08-28
CA2522734A1 (en) 2004-11-04
CN101468999A (zh) 2009-07-01
HU0301082D0 (en) 2003-06-28
EA008376B1 (ru) 2007-04-27
EP1620439B1 (en) 2008-07-16
JP2006524219A (ja) 2006-10-26
HU226410B1 (en) 2008-11-28
JP4763594B2 (ja) 2011-08-31
EP1620439A1 (en) 2006-02-01
AU2004232544A1 (en) 2004-11-04
PL1620439T3 (pl) 2009-02-27
SK50942005A3 (sk) 2006-02-02
PT1620439E (pt) 2008-10-23
PL378061A1 (pl) 2006-02-20
CN100471859C (zh) 2009-03-25
SI1620439T1 (sl) 2009-06-30
ES2310728T3 (es) 2009-01-16
CZ2005684A3 (cs) 2006-01-11
DK1620439T3 (da) 2008-11-17
UA80881C2 (en) 2007-11-12
IL171522A (en) 2010-05-31
US7951798B2 (en) 2011-05-31
CN1777613A (zh) 2006-05-24
AU2004232544B2 (en) 2010-06-03
CA2522734C (en) 2010-05-25
ZA200508936B (en) 2008-07-30
BG109361A (bg) 2006-09-29
HRP20080479T3 (en) 2008-10-31
EA200501633A1 (ru) 2006-04-28
ATE401332T1 (de) 2008-08-15
US20070004706A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
YU58103A (sh) Farmaceutski preparati, dozirane forme i postupci za oralnu primenu epotilona
EE9900539A (et) Uued ühendid
YU12103A (sh) Polimorfni oblici epotilonskog analoga
HUP0203257A2 (hu) Atorvastatin kalcium polimorf módosulatai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0302474A2 (hu) Terápiásan hatásos tropánszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AR002719A1 (es) Forma ii polimorfa 2-metil-4-(4-metil-1-piperacinil)-10h-tieno[2,3-b]-[1,5] benzodiacepina(olanzapina) y formulaciones farmaceuticas que las contienen.
HUP0301082A2 (hu) Új polimorf olanzapine hidroklorid sók, eljárás ezek előállítására, az ezeket tartalmazó gyógyászati készítmények és felhasználásuk
HUP0302874A2 (hu) Eljárás risperidon előállítására
HUP0402270A2 (hu) [1,2,4]Triazolo[1,5-c]pirimidin-5-il-aminok mint adenozin A2a receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények
TW200606164A (en) New compounds
HUP0200438A2 (hu) Polimorf clopidogrel-hidroklorid-sók, az ezeket tartalmazó gyógyszerkészítmények és eljárás mindezek elżállítására
HUP0300701A2 (hu) Zolpidem hemitartarát, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
IS6437A (is) Ný setin pýrazóló [4,3-e]díazepín lyfjasamsetningar sem innihalda þau, notkun sem læknandi afurðir og aðferðir við framleiðslu þeirra
CA2548078A1 (en) Pharmaceutical formulations of camptothecins and process for making same
WO2002034203A3 (en) Novel derivatives of phenyl 4-aminosalicylate and method of making the same
DE602006021792D1 (de) Verfahren zur herstellung von olanzapin
HUP0204297A2 (hu) (-)-cisz-2-(2-Klór-fenil)-5,7-dihidroxi-8-[4R-(3S-hidroxi-1-metil)-piperidinil]-4H-1-benzopirán-4-on etanolos szolvátja, eljárás az előállítására és ezeket tartalmazó gyógyszerkészítmények
HUP0204126A2 (hu) (-)-cisz-2-(2-Klór-fenil)-5,7-dihidroxi-8-[4R-(3S-hidroxi-1-metil-piperidinil)]-4H-1-benzopirán-4-on pszeudopolimorfja, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDOE RESZV, HU

Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR RT., HU

MM4A Lapse of definitive patent protection due to non-payment of fees